Antibiotics GE23077, Novel Inhibitors of Bacterial RNA Polymerase: I. Taxonomy, Isolation and Characterization

GE 23077 factors A1, A2, B1 and B2 are novel antibiotics isolated from fermentation broths of an Actinomadura sp. strain. GE23077 antibiotics are cyclic peptides, which inhibit Escherichia coli RNA polymerase at nM concentrations. Both rifampicin-sensitive and rifampicin-resistant polymerases are in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antibiotics 2004/03/25, Vol.57(3), pp.210-217
Hauptverfasser: CICILIATO, ISMAELA, CORTI, EMILIANA, SARUBBI, EDOARDO, STEFANELLI, STEFANIA, GASTALDO, LUCIANO, MONTANINI, NICOLETTA, KURZ, MICHAEL, LOSI, DANIELE, MARINELLI, FLAVIA, SELVA, ENRICO
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:GE 23077 factors A1, A2, B1 and B2 are novel antibiotics isolated from fermentation broths of an Actinomadura sp. strain. GE23077 antibiotics are cyclic peptides, which inhibit Escherichia coli RNA polymerase at nM concentrations. Both rifampicin-sensitive and rifampicin-resistant polymerases are inhibited, whereas E. coli DNA polymerase and wheat germ RNA polymerase are substantially not affected. In spite of the potent activity on the enzyme, the antibiotics generally show poor activity against whole cell bacteria. The spectrum of activity is restricted to Moraxella catarrhalis, including clinical isolates, with partial activity against Neisseria gonorrhoeae and Mycobacterium smegmatis.
ISSN:0021-8820
1881-1469
DOI:10.7164/antibiotics.57.210